High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma
Authors:
- Xin ZhangXZXin Zhang
- Meile MoMMMeile Mo
- Zhong TanZTZhong Tan
- Lanshan HuangLHLanshan Huang
- Hong ZhouHZHong Zhou
- Chunqin WangCWChunqin Wang
- Fanglin WeiFWFanglin Wei
- Xiaohui QiuXQXiaohui Qiu
- Rongquan HeRHRongquan He
- Gang ChenGCGang Chen
Open Access
- 1 April 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (15) , e3337
Abstract
Ki-67 is considered as one of prime biomarkers to reflect cell proliferation and immunohistochemical Ki-67 staining has been widely applied in clinical pathology. To solve the widespread controversy whether Ki-67 reactivity significantly predicts clinical prognosis of bladder carcinoma (BC), we performed a comprehensive meta-analysis by combining results from different literature. A comprehensive search was conducted in the Chinese databases of WanFang, China National Knowledge Infrastructure and Chinese VIP as well as English databases of PubMed, ISI web of science, EMBASE, Science Direct, and Wiley online library. Independent studies linking Ki-67 to cancer-specific survival (CSS), disease-free survival (DFS), overall survival (OS), progression-free survival (PFS), and recurrence-free survival (RFS) were included in our meta-analysis. With the cut-off values literature provided, hazard ratio (HR) values between the survival distributions were extracted and later combined with STATA 12.0. In total, 76 studies (n = 13,053 patients) were eligible for the meta-analysis. It was indicated in either univariate or multivariate analysis for survival that high Ki-67 reactivity significantly predicted poor prognosis. In the univariate analysis, the combined HR for CSS, DFS, OS, PFS, and RFS were 2.588 (95% confidence interval [CI]: 1.623-4.127, P < 0.001), 2.697 (95%CI: 1.874-3.883, P < 0.001), 2.649 (95%CI: 1.632-4.300, P < 0.001), 3.506 (95%CI: 2.231-5.508, P < 0.001), and 1.792 (95%CI: 1.409-2.279, P < 0.001), respectively. The pooled HR of multivariate analysis for CSS, DFS, OS, PFS, and RFS were 1.868 (95%CI: 1.343-2.597, P < 0.001), 2.626 (95%CI: 2.089-3.301, P < 0.001), 1.104 (95%CI: 1.008-1.209, P = 0.032), 1.518 (95%CI: 1.299-1.773, P < 0.001), and 1.294 (95%CI: 1.203-1.392, P < 0.001), respectively. Subgroup analysis of univariate analysis by origin showed that Ki-67 reactivity significantly correlated with all 5 clinical outcome in Asian and European-American patients (P < 0.05). For multivariate analysis, however, the pooled results were only significant for DFS, OS, and RFS in Asian patients, for CSS, DFS, PFS, and RFS in European-American patients (P < 0.05). In the subgroup with low cut-off value (<20%), our meta-analysis indicated that high Ki-67 reactivity was significantly correlated with worsened CSS, DFS, OS, PFS, and RFS on univariate analysis (P < 0.05). For multivariate analysis, the meta-analysis of literature with low cut-off value (<20%) demonstrated that high Ki-67 reactivity predicted shorter DFS, PFS, and RFS in BC patients (P < 0.05). In the subgroup analysis of high cut-off value (≥20%), our meta-analysis indicated that high Ki-67 reactivity, in either univariate or multivariate analysis, significantly correlated with all five clinical outcomes in BC patients (P < 0.05). The meta-analysis indicates that high Ki-67 reactivity significantly correlates with deteriorated clinical outcomes in BC patients and that Ki-67 can be considered as an independent indicator for the prognosis by the meta-analyses of multivariate analysis.Keywords
This publication has 137 references indexed in Scilit:
- Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-AnalysisPLOS ONE, 2013
- Expression and Role of GPR87 in Urothelial Carcinoma of the BladderInternational Journal of Molecular Sciences, 2013
- Expression of Fibroblast Growth Factor Receptor 3 in the Recurrence of Non-Muscle-Invasive Urothelial Carcinoma of the BladderKorean Journal of Urology, 2010
- Expression of the Endothelin Axis in Noninvasive and Superficially Invasive Bladder Cancer: Relation to Clinicopathologic and Molecular Prognostic ParametersEuropean Urology, 2009
- Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical CystectomyJournal of Urology, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladderBritish Journal of Cancer, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- BILHARZIAL RELATED, ORGAN CONFINED, MUSCLE INVASIVE BLADDER CANCER: PROGNOSTIC VALUE OF APOPTOSIS MARKERS, PROLIFERATION MARKERS, p53, E-CADHERIN, EPIDERMAL GROWTH FACTOR RECEPTOR AND c-erbB-2Journal of Urology, 2001